Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Reducción Dramática de VSR: Experiencia del Instituto de Medicina Tropical de Paraguay

En esta cápsula médica del Congreso Europeo de Infectología Pediátrica (ESPID) Bolonia 2026, la Dra. Celia Martínez de Cuéllar presenta los resultados extraordinarios en la reducción de casos de VSR en el Instituto de Medicina Tropical de Paraguay.

Perspectiva Latinoamericana en Infectología Pediátrica Global

En esta cápsula médica del Congreso Europeo de Infectología Pediátrica (ESPID) Bolonia 2026, el Dr. José María Solano Suárez comparte su perspectiva como representante latinoamericano sobre los desafíos globales en infectología pediátrica y la importancia de la colaboración internacional.
 

Reducción Dramática de VSR: Experiencia del Instituto de Medicina Tropical de Paraguay

En esta cápsula médica del Congreso Europeo de Infectología Pediátrica (ESPID) Bolonia 2026, la Dra. Celia Martínez de Cuéllar presenta los resultados extraordinarios en la reducción de casos de VSR en el Instituto de Medicina Tropical de Paraguay.
 

Estrategias Combinadas de Prevención contra VSR en Latinoamérica

En esta cápsula médica del Congreso Europeo de Infectología Pediátrica (ESPID) Bolonia 2026, el Dr. Oscar Tamez analiza las estrategias combinadas de prevención contra el virus sincitial respiratorio y su efectividad en México y Latinoamérica.

SKINPULSE PODCAST: Where skin meets science

Type 2 inflammation connects conditions that appear unrelated. Yet the connections are often missed. SKINPULSE exists to change that. Each episode brings together leading clinical experts to explore the systemic drivers behind what you see on the skin — translating complex science into insights that are relevant, accessible, and immediately applicable to your practice.

SKINPULSE PODCAST: Where skin meets science

Type 2 inflammation connects conditions that appear unrelated. Yet the connections are often missed. SKINPULSE exists to change that. Each episode brings together leading clinical experts to explore the systemic drivers behind what you see on the skin — translating complex science into insights that are relevant, accessible, and immediately applicable to your practice.

SKINPULSE PODCAST: Where skin meets science

Type 2 inflammation connects conditions that appear unrelated. Yet the connections are often missed. SKINPULSE exists to change that. Each episode brings together leading clinical experts to explore the systemic drivers behind what you see on the skin — translating complex science into insights that are relevant, accessible, and immediately applicable to your practice.

SKINPULSE PODCAST: Where skin meets science

Type 2 inflammation connects conditions that appear unrelated. Yet the connections are often missed. SKINPULSE exists to change that. Each episode brings together leading clinical experts to explore the systemic drivers behind what you see on the skin — translating complex science into insights that are relevant, accessible, and immediately applicable to your practice.

SKINPULSE PODCAST: Where skin meets science

Type 2 inflammation connects conditions that appear unrelated. Yet the connections are often missed. SKINPULSE exists to change that. Each episode brings together leading clinical experts to explore the systemic drivers behind what you see on the skin — translating complex science into insights that are relevant, accessible, and immediately applicable to your practice.

Islet autoantibodies as biomarkers of progression to clinical T1D

Prof Bonifacio discusses the predictive value and utility of islet autoantibodies as biomarkers of the risk and rate of progression to clinical T1D 

Composite risk scores as tools for improved T1D risk prediction

Prof. Wentworth discusses how T1D risk prediction can be improved through the development of tools that integrate multiple risk factors and biomarkers 

Immune dysregulation in T1D: biomarkers and therapeutic targets

Profs. Kay and Bonifacio discuss the role of T-cell dysregulation as a central pathophysiological mechanism in T1D, and its implications for emerging therapies and biomarkers